Loading clinical trials...
Loading clinical trials...
Mechanism of Chemoreflex and Baroreflex Alterations Causing Postural Tachycardia Syndrome in POTS Patients With Orthostatic Hyperpnea and Hypocapnia
Conditions
Interventions
Chemoreflex Testing
Baroreflex testing
+1 more
Locations
1
United States
NewYork Medical College
Hawthorne, New York, United States
Start Date
September 23, 2022
Primary Completion Date
August 31, 2023
Completion Date
August 31, 2024
Last Updated
June 28, 2023
NCT06593600
NCT07196397
NCT06616363
NCT06936319
NCT05846425
NCT04258774
Lead Sponsor
New York Medical College
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions